Brain zaps for young minds: can TMS ease anxiety and depression?

NCT ID NCT06892847

Recruiting now Symptom relief Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether transcranial magnetic stimulation (TMS) can reduce anxiety and depression in children and teens aged 6 to 18. About 120 participants will receive TMS treatment, and researchers will track symptom changes using questionnaires. The goal is to see if this brain stimulation technique can help young people who are struggling with these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Magnetic Stimulation (TMS)
What this could lead to: If it works, this could offer a non-drug treatment option for young people with anxiety and depression.
What could go wrong: This is an early open-label trial with no placebo group, so results may be due to expectation. TMS is generally safe but can cause discomfort or rare seizures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS DEPRESSION

Contacts and locations

Locations

Alberta Children's Hospital
RECRUITING

Calgary, Alberta, T3B 6A8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.